Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
Here are nine key points:
1. InVivo experienced a net loss of about $5.18 million, or $0.16 per diluted share. This compares to a net loss of $10.44 billion, or $0.39 per diluted share for the same period in 2015.
2. At the end of the quarter, the company had $41.63 million in cash and cash equivalents.
3. A gain in the derivative warrant liability of $595,000 positively affected the company's second quarter results. However, a loss in the deferred warrant liability of $4.65 million negatively impacted the second quarter 2016 results.
4. The company's adjusted net loss per diluted share totaled $0.18, compared to $0.21 in the second quarter of 2015.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies